Fox Run Management L.L.C. acquired a new stake in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 33,199 shares of the company's stock, valued at approximately $463,000. Fox Run Management L.L.C. owned approximately 0.12% of ZimVie at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. SG Americas Securities LLC raised its stake in shares of ZimVie by 15.7% during the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock worth $155,000 after acquiring an additional 1,508 shares in the last quarter. EMC Capital Management raised its position in ZimVie by 47.0% in the 4th quarter. EMC Capital Management now owns 13,802 shares of the company's stock worth $193,000 after purchasing an additional 4,414 shares during the period. Principal Financial Group Inc. bought a new stake in ZimVie in the third quarter worth $275,000. Bailard Inc. boosted its position in ZimVie by 35.0% during the fourth quarter. Bailard Inc. now owns 21,194 shares of the company's stock valued at $296,000 after buying an additional 5,494 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in ZimVie during the third quarter valued at about $470,000. Institutional investors own 95.63% of the company's stock.
ZimVie Trading Down 5.2 %
ZIMV stock traded down $0.60 during midday trading on Friday, hitting $10.91. The company had a trading volume of 142,158 shares, compared to its average volume of 232,244. The stock has a market cap of $301.96 million, a price-to-earnings ratio of -0.83 and a beta of 2.10. ZimVie Inc. has a 52 week low of $10.75 and a 52 week high of $22.40. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. The stock's 50 day moving average price is $13.07 and its 200 day moving average price is $14.03.
ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.02. The company had revenue of $111.52 million during the quarter, compared to analyst estimates of $113.67 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. As a group, equities research analysts expect that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Separately, Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a research note on Thursday, March 13th.
Read Our Latest Research Report on ZimVie
About ZimVie
(
Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Further Reading
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
